<DOC>
	<DOCNO>NCT00159380</DOCNO>
	<brief_summary>The primary aim study investigate effect oral inhaled administration L-arginine inhale aminoguanidine bronchial alveolar exhale NO NO metabolites exhale breath condensate , saliva nasal lavage fluid normal asthmatic subject .</brief_summary>
	<brief_title>Nitric Oxide ( NO ) Donors Inhibitors Study : Study Evaluate L-Arginine Aminoguanidine Asthmatic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pimagedine</mesh_term>
	<criteria>Healthy nonsmoker ( n=10 ) : Nonatopic subject ( exhale NO great equal 10 ppb ; flow 50 ml/s ) Normal spirometry Able comprehend grant write informed consent Asthmatic subject ( n=15 ) : Forced expiratory volume one second ( FEV1 ) less 70 % predict ( exhaled NO great equal 15 ppb ; flow 50 ml/s ) Clinically stable ( steroidna√Øve take &gt; 600 mcg/day inhale steroid ) Able comprehend grant write informed consent Currently smoke Any lung disease asthma may interfere study Treatment within last 4 week oral steroid Respiratory infection within 4 week prior entry trial Females pregnant lactate History current past drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>